Microbiological Considerations for Ophthalmic Products: Sterility, Endotoxin Limits, and Preservatives

All ophthalmic products must meet regulatory standards for microbiological quality and safety for their intended use. This chapter outlines holistic control strategies for sterility, endotoxin, and preservative efficacy to achieve ophthalmic product safety. While finished product testing for sterility or pyrogens confirms the microbiological quality of the products, there are certain challenges in developing a sensitive microbiological test that assures product quality. Product matrices/composition may interfere with the test. Additionally, testing only a small portion of the batch poses a statistical challenge to the confirmation of product quality of the entire batch. Therefore, stringent microbiological control cannot solely rely on end-product testing. The risk of microbial and/or pyrogenic contamination can be minimized only when proper microbiological control strategies, employed throughout the manufacturing process, are combined with finished product testing. While proper manufacturing process control provides assurance to the finished product microbiological quality, preservatives in a formulation are added to provide adequate protection from microbial contamination or proliferation that may arise during the use of the product. Preservative concentration must be safe to the patient but must robustly meet the requirements for preservative effectiveness of killing microorganisms for ophthalmic products.